Orion Oyj : The Board of Directors of Orion Corporation decided on an incentive plan for key persons

    Orion Oyj : The Board of Directors of Orion Corporation decided on an
                        incentive plan for key persons


The Board of Directors of Orion Corporation has decided on a new share-based
incentive plan for the Group key persons. The aim of the Plan is to combine
the objectives of the shareholders and the key persons in order to increase
the value of the Company, to commit the key persons to the Company, and to
offer them a competitive reward plan based on holding the Company's shares.

The Plan includes earning periods. The Board of Directors decides annually on
the beginning and duration of the earning periods in 2013, 2014 and 2015. The
Board of Directors decides on the earnings criteria and on targets to be
established for them at the beginning of each earning period. Two earning
periods, calendar year 2013 and calendar years 2013-2015, commenced upon
implementation of the Plan. The potential reward of the Plan, for the earning
period 2013, is based on the Orion Group's operating profit and, for the
earning period 2013-2015, on the total return on Orion Corporation class B

The potential reward will be paid partly as the Company's class B shares and
partly in cash in 2014, on the basis of the earning period 2013, and in 2016
on the basis of the earning period 2013-2015. The proportion to be paid in
cash will be used for taxes and tax-related costs arising from the reward to a
key person. The value of reward to be paid on the basis of the Plan and the
Orion Share-based incentive plan established in 2010 during one calendar year
is a key person's gross annual salary multiplied by 1.75, in the maximum, at
the date of the reward payment. Gross annual salary means total salary
together with fringe benefits, excluding annual bonus and long-term incentive
plan. The shares paid on the basis of the earning period 2013 cannot be
transferred during the restriction period, which will end on 31 December 2015
with the exception that notwithstanding the transfer restrictions relating to
the shares to be paid on the basis of the Plan, a person belonging to the Plan
may purchase Orion Corporation A shares at will and at his/her expense on the
stock exchange or otherwise and enter these shares under the transfer
restriction of the Plan, and after the acquisition transfer a corresponding
number of B shares under the transfer restriction.
The target group of the Plan consists of approximately 35 people. The total
maximum amount of rewards to be paid on the basis of the Plan is 500,000 Orion
Corporation class B shares and a cash payment corresponding to the value of
the shares.

Orion Corporation

Timo Lappalainen  Olli Huotari
President and CEO SVP, Corporate Functions 

Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10426 3054, mobile +358
50966 3054

Orion Corporation
Orionintie 1A, FI-02200 Espoo

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler^® pulmonary

Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.